Univentricular heart is a complex group of congenital heart conditions that share a common challenge: only one chamber in the heart is strong enough to support the body’s circulation. This means children born with these conditions face significant medical hurdles from the very beginning of life, requiring specialized surgical interventions and lifelong monitoring to sustain their heart function.

When Half a Heart Must Do the Work of a Whole One

The term univentricular heart refers to a collection of congenital heart defects where one of the two lower pumping chambers—the ventricles—is either too small, underdeveloped, missing a valve, or in rare cases, absent altogether. In a healthy heart, the right ventricle pumps oxygen-poor blood to the lungs, while the left ventricle pumps oxygen-rich blood to the rest of the body. When one ventricle cannot perform its role, the remaining ventricle must handle both jobs, creating a functional univentricular heart.^[1][2]

These conditions are sometimes called “functionally univentricular hearts” because the entire ventricular mass functions as a single chamber, even when two ventricles are physically present but one is too weak. The definition that best captures this reality states that a heart is functionally univentricular “whenever one or other ventricle was incapable, for whatever reason, of supporting either the systemic or the pulmonary circulation.”^[4] This functional limitation defines the course of treatment and the type of surgical repair needed.

Several specific heart defects fall under this umbrella. Hypoplastic left heart syndrome (HLHS) is one of the most severe, where the left side of the heart is critically underdeveloped. Tricuspid atresia occurs when the valve linking the right atrium and right ventricle is closed or missing, leaving the right ventricle too small to function. Double inlet ventricle describes a condition where both upper chambers (atria) pump blood into a single ventricle, leaving the other ventricle very small and incomplete.^[3][4] Other conditions include pulmonary atresia, extreme cases of Ebstein’s anomaly, and certain forms of transposition of the great arteries.^[2]

The goal of treating univentricular heart is not to cure the condition, but to manage it in a way that allows the child to survive and, ideally, to thrive. Treatment focuses on controlling symptoms, ensuring adequate blood flow to the lungs and body, preventing complications such as heart failure or developmental delays, and improving quality of life. Since these hearts cannot be fully repaired to function like a normal two-chambered system, the surgical strategy aims to create a stable single-ventricle circulation that can sustain life into adulthood.^[5][6]

Standard Surgical Treatment: The Staged Reconstruction Approach

The standard treatment for most children with univentricular heart involves a series of carefully timed surgeries performed over several years. This approach is often referred to as staged reconstruction or the Fontan pathway, named after the surgeon who pioneered this life-saving technique. The ultimate goal is to establish what is called Fontan circulation, where the single functional ventricle pumps oxygenated blood to the body, while oxygen-poor blood flows passively from the veins directly to the lungs without passing through the heart.^[9][10]

Stage 1: Neonatal Palliation (First Days of Life)

The first surgery typically occurs within days after birth. This operation is critical because without it, the newborn cannot survive. The specific procedure depends on the type of heart defect. For babies with hypoplastic left heart syndrome, the Norwood procedure is the most common first-stage operation. During this complex surgery, the surgeon reconstructs the aorta and ensures that the single functioning ventricle can pump blood to the body. A small tube or shunt is placed to control blood flow to the lungs, preventing too much or too little blood from reaching them.^[6][10]

For other types of univentricular hearts, the neonatal stage may involve different interventions. Some infants need a procedure to restrict blood flow to the lungs if it is too high, which can be achieved through pulmonary artery banding. Others may need a shunt placed to increase blood flow to the lungs if it is too low, particularly in cases of pulmonary atresia or severe stenosis.^[6] The immediate post-operative period is delicate, with babies requiring intensive monitoring in specialized cardiac units to manage potential complications such as low oxygen levels, heart rhythm problems, or infections.

Stage 2: The Glenn or Hemi-Fontan Procedure (Around 4 to 6 Months)

The second stage usually occurs when the infant is between four and six months old. This surgery is called the Glenn procedure or hemi-Fontan operation, depending on the specific technique used. During this operation, the superior vena cava—a large vein that carries oxygen-poor blood from the upper body—is disconnected from the heart and connected directly to the pulmonary artery. This allows blood from the upper half of the body to flow passively into the lungs without being pumped by the heart.^[10]

This intermediate step reduces the workload on the single ventricle, which now only needs to pump oxygenated blood to the body and receive blood from the lower body. The Glenn procedure is an important bridge toward the final surgery, allowing the child to grow stronger and the pulmonary blood vessels to mature. Recovery from this surgery is generally smoother than the first stage, but children still require careful follow-up with regular echocardiograms and other tests to monitor heart function and oxygen levels.^[9]

Stage 3: The Fontan Procedure (Around 2 to 4 Years)

The final surgery, the Fontan procedure, is typically performed when the child is between two and four years old. This operation completes the separation of oxygen-rich and oxygen-poor blood. The inferior vena cava—the large vein carrying blood from the lower body—is also connected directly to the pulmonary arteries. Now all oxygen-poor blood from the body flows passively to the lungs, and the single ventricle is responsible only for pumping oxygenated blood to the body.^[9][10]

This final configuration is called Fontan circulation. It is not a normal circulation, but it is a functional one that can sustain life. The major difference from a healthy heart is the absence of a ventricle actively pumping blood to the lungs. Instead, blood flows to the lungs based on pressure differences, which means that the system is more fragile and sensitive to factors that affect blood flow, such as dehydration, illness, or physical exertion.^[9]

Children who complete the Fontan pathway require lifelong monitoring by cardiologists specializing in congenital heart disease. Even if they feel well, regular check-ups are essential to detect and address complications early. Common issues include arrhythmias (irregular heart rhythms), blood clots, liver problems, and fluid accumulation in the abdomen or around the lungs. Some patients develop protein-losing enteropathy, a condition where the intestines lose protein, leading to swelling and malnutrition.^[13]

Medications and Supportive Care

In addition to surgery, children with univentricular hearts often require medications to support heart function and prevent complications. Anticoagulants such as aspirin or warfarin are commonly prescribed after the Fontan procedure to reduce the risk of blood clots forming in the slow-moving blood within the modified circulation. These medications require regular blood tests to monitor their effectiveness and ensure safe dosing.^[8]

Some children may need medications to manage heart failure symptoms, such as diuretics to reduce fluid buildup, or drugs to support heart muscle contraction. Others may require medications to control arrhythmias or blood pressure. The specific medication regimen is tailored to each child’s condition and adjusted over time based on their evolving needs.^[12]

Nutrition is another critical aspect of care. Infants with univentricular hearts often struggle to gain weight due to the increased energy demands of a poorly functioning circulation. Some may need high-calorie formulas or even feeding tubes to ensure adequate nutrition for growth and development. As children grow, maintaining a heart-healthy diet and avoiding obesity become important to reduce strain on the heart.^[12]

Innovative Treatments Being Tested in Clinical Trials

While the Fontan pathway has transformed the outlook for children with univentricular hearts, it is not a perfect solution. Many patients experience complications as they age, and the Fontan circulation can eventually fail. This has driven researchers to explore new therapies and surgical techniques that could improve outcomes or even provide alternatives to traditional staged reconstruction.

One area of active investigation is the hybrid approach to Stage 1 palliation. Instead of performing open-heart surgery immediately after birth, some centers are testing a combination of catheter-based procedures and surgical interventions. This hybrid strategy aims to reduce the trauma of major surgery in fragile newborns, potentially improving survival and reducing complications. Early-phase clinical trials are comparing outcomes between the traditional Norwood procedure and hybrid approaches to determine which is safer and more effective.^[5]

Researchers are also studying ways to improve the long-term durability of Fontan circulation. One challenge is that the passive flow of blood to the lungs can lead to increased pressure in the veins, causing liver damage and fluid accumulation over time. Some clinical trials are testing new surgical modifications to the Fontan circuit that may reduce these pressures and improve blood flow. These modifications are still in early phases of testing and involve careful monitoring of hemodynamic parameters to assess their impact.^[9]

Another promising area is the development of mechanical circulatory support devices specifically designed for Fontan patients. Traditional ventricular assist devices are built for two-ventricle hearts, so they don’t work well for univentricular circulations. Engineers and clinicians are collaborating to design pumps that can assist Fontan circulation by actively moving blood from the veins to the lungs, reducing the strain on the system. These devices are being tested in Phase I and Phase II trials, with a focus on safety and whether they can improve exercise capacity and reduce symptoms in failing Fontan patients.^[9]

Gene therapy and regenerative medicine are also on the horizon, though they remain in very early research stages. Scientists are exploring whether it might be possible to stimulate the growth of heart muscle or even regenerate a missing or underdeveloped ventricle using stem cells or genetic interventions. These approaches are largely experimental and are being tested in animal models before any human trials can begin. The goal would be to eventually offer a biological repair rather than relying solely on surgical rerouting of blood flow.^[5]

In the realm of medications, researchers are investigating drugs that could protect the liver and intestines from the damaging effects of chronically elevated venous pressure in Fontan patients. Some studies are examining whether certain medications used in other forms of heart failure might also benefit univentricular heart patients, though results are still preliminary. Clinical trials are underway in Europe and the United States to test these interventions, with patient eligibility typically limited to those who have already undergone the Fontan procedure and are experiencing specific complications.^[9]

Living with a Univentricular Heart: Long-Term Outlook and Challenges

Thanks to advances in surgery and medical care, many children born with univentricular hearts now survive into adulthood. However, living with this condition presents ongoing challenges. Patients must remain under the care of cardiologists who specialize in adult congenital heart disease, as their needs differ from those of people with typical heart conditions or even children with congenital defects.^[12]

Physical activity is often limited for people with univentricular hearts. The passive Fontan circulation is less efficient than a normal two-ventricle system, which means that patients may tire more easily and cannot reach the same levels of exertion as their peers. While moderate exercise is generally encouraged to maintain cardiovascular fitness and overall health, strenuous or competitive sports are typically discouraged due to the risk of complications.^[12][13]

Emotional and psychological challenges are also common. Children growing up with a serious heart condition may experience anxiety, feelings of being different from their peers, or uncertainty about the future. Parents often feel overwhelmed by the demands of managing complex medical care, coordinating appointments, and making difficult decisions about treatments. Support from mental health professionals, social workers, and patient advocacy groups can be invaluable in helping families cope with these stresses.^[16]

For women with univentricular hearts, pregnancy carries significant risks. The increased demands on the cardiovascular system during pregnancy can lead to dangerous complications, including heart failure or arrhythmias. Women considering pregnancy should have detailed discussions with their cardiologists and maternal-fetal medicine specialists to understand the risks and plan carefully if they choose to proceed.^[12]

As Fontan patients age, the risk of late complications increases. Some may experience progressive heart failure, requiring consideration of heart transplantation. Others may develop significant arrhythmias that require medications, catheter-based procedures, or implantable devices to control. Liver disease related to chronic venous congestion is another concern that requires monitoring with blood tests and imaging studies. Staying organized with medical records, understanding one’s specific heart anatomy, and maintaining open communication with the healthcare team are critical for long-term success.^[12][13]

Most Common Treatment Methods

• Staged Surgical Reconstruction (Fontan Pathway)
  • Stage 1: Norwood procedure or other neonatal palliation performed within days of birth to establish systemic blood flow and control pulmonary blood flow.
  • Stage 2: Glenn or hemi-Fontan procedure around 4-6 months of age, connecting the superior vena cava directly to the pulmonary arteries.
  • Stage 3: Fontan procedure around 2-4 years of age, completing the redirection of venous blood to the lungs and establishing final single-ventricle circulation.
• Anticoagulation Therapy
  • Use of aspirin or warfarin to prevent blood clots in the Fontan circulation where blood flows more slowly.
  • Requires regular monitoring with blood tests to ensure safe and effective dosing.
• Heart Failure Medications
  • Diuretics to reduce fluid buildup and swelling.
  • Medications to support heart muscle contraction and manage blood pressure.
  • Drugs to control irregular heart rhythms (arrhythmias).
• Nutritional Support
  • High-calorie formulas or feeding tubes for infants who struggle to gain weight.
  • Heart-healthy diet recommendations for older children and adults.
• Cardiac Catheterization Procedures
  • Minimally invasive procedures to address complications such as narrowing of blood vessels or Fontan conduit stenosis.
  • Stent placement to open blocked or narrowed areas and improve blood flow.
• Heart Transplantation
  • Considered for patients with failing Fontan circulation who develop severe heart failure.
  • Requires careful evaluation and lifelong immunosuppressive medications after transplant.